DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
PAGOCLONE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
GABA-A receptor; anion channel positive allosteric modulator
PAGOCLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
38VAG2SA33
Molecule Type:
Small molecule
Molecular Formula:
C23H22ClN3O2
Molecular Weight:
407.9
AlogP:
5.38
PSA:
63.16
HBD:
0.0
HBA:
#RotB:
6.0
Source:
RADALBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
RADALBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
273K4V0SPC
Molecule Type:
Small molecule
Molecular Formula:
C30H41NO6S
Molecular Weight:
543.73
AlogP:
5.4
PSA:
96.3
HBD:
2.0
HBA:
#RotB:
7.0
Source:
OSORESNONTRINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Mental Disorders; Schizophrenia
Unknown
OSORESNONTRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
O9OC34WOAY
Molecule Type:
Small molecule
Molecular Formula:
C16H17N5O2
Molecular Weight:
311.35
AlogP:
1.46
PSA:
85.69
HBD:
1.0
HBA:
#RotB:
3.0
Source:
VILANTEROL .ALPHA.-PHENYL CINNAMATE
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
VILANTEROL .ALPHA.-PHENYL CINNAMATE
×
Maximum Phase:
2
First Approval:
None
UNII:
DB71X3OVN2
Molecule Type:
Small molecule
Molecular Formula:
C39H45Cl2NO7
Molecular Weight:
710.7
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NEPICASTAT
2
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Stress Disorders, Post-Traumatic
Unknown
NEPICASTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
VPG12K4540
Molecule Type:
Small molecule
Molecular Formula:
C14H15F2N3S
Molecular Weight:
295.36
AlogP:
2.64
PSA:
43.84
HBD:
2.0
HBA:
#RotB:
2.0
Source:
CINACIGUAT
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure
Soluble guanylate cyclase activator
CINACIGUAT
×
Maximum Phase:
2
First Approval:
None
UNII:
59K0Y58UAD
Molecule Type:
Small molecule
Molecular Formula:
C36H39NO5
Molecular Weight:
565.71
AlogP:
7.05
PSA:
87.07
HBD:
2.0
HBA:
#RotB:
17.0
Source:
RALMITARONT
2
Small molecule
Investigational
Unknown
Unknown
Psychotic Disorders
Unknown
RALMITARONT
×
Maximum Phase:
2
First Approval:
None
UNII:
QA8MW1Q80P
Molecule Type:
Small molecule
Molecular Formula:
C17H22N4O2
Molecular Weight:
314.39
AlogP:
2.19
PSA:
79.04
HBD:
3.0
HBA:
#RotB:
4.0
Source:
SOTRASTAURIN
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Lymphoma, Large B-Cell, Diffuse; Colitis, Ulcerative; Psoriasis; Uveitis, Posterior
Protein kinase C (PKC) inhibitor
SOTRASTAURIN
×
Maximum Phase:
2
First Approval:
None
UNII:
7I279E1NZ8
Molecule Type:
Small molecule
Molecular Formula:
C25H22N6O2
Molecular Weight:
438.49
AlogP:
2.43
PSA:
94.22
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FILOREXANT
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Diabetic Neuropathies; Sleep Initiation and Maintenance Disorders
Orexin receptor antagonist
FILOREXANT
×
Maximum Phase:
2
First Approval:
None
UNII:
E6BTT8VA5Z
Molecule Type:
Small molecule
Molecular Formula:
C24H25FN4O2
Molecular Weight:
420.49
AlogP:
4.31
PSA:
68.21
HBD:
0.0
HBA:
#RotB:
5.0
Source:
O-CHLOROACETYLCARBAMOYLFUMAGILLOL
2
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Unknown
O-CHLOROACETYLCARBAMOYLFUMAGILLOL
×
Maximum Phase:
2
First Approval:
None
UNII:
X47GR46481
Molecule Type:
Small molecule
Molecular Formula:
C19H28ClNO6
Molecular Weight:
401.89
AlogP:
2.55
PSA:
89.69
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GW590735
2
Small molecule
Investigational
Unknown
Unknown
Lipid Metabolism Disorders
Peroxisome proliferator-activated receptor alpha agonist
GW590735
×
Maximum Phase:
2
First Approval:
None
UNII:
QKY617BBX5
Molecule Type:
Small molecule
Molecular Formula:
C23H21F3N2O4S
Molecular Weight:
478.49
AlogP:
5.31
PSA:
88.52
HBD:
2.0
HBA:
#RotB:
7.0
Source:
STG-001
2
Small molecule
Investigational
Unknown
Unknown
Stargardt Disease
Unknown
STG-001
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C14H10F6N2O2
Molecular Weight:
352.23
AlogP:
4.06
PSA:
55.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
UK-390957
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UK-390957
×
Maximum Phase:
2
First Approval:
None
UNII:
W26I0D1D6J
Molecule Type:
Small molecule
Molecular Formula:
C16H20N2O3S2
Molecular Weight:
352.48
AlogP:
2.91
PSA:
72.63
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CHF-6001
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Phosphodiesterase 4 inhibitor
CHF-6001
×
Maximum Phase:
2
First Approval:
None
UNII:
0984EU6E2F
Molecule Type:
Small molecule
Molecular Formula:
C30H30Cl2F2N2O8S
Molecular Weight:
687.54
AlogP:
6.32
PSA:
127.1
HBD:
1.0
HBA:
#RotB:
15.0
Source:
TAS-117
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase AKT negative allosteric modulator
TAS-117
×
Maximum Phase:
2
First Approval:
None
UNII:
QI52W1ZIIB
Molecule Type:
Small molecule
Molecular Formula:
C26H24N4O2
Molecular Weight:
424.5
AlogP:
4.33
PSA:
86.19
HBD:
2.0
HBA:
#RotB:
3.0
Source:
7-ETHYL-10-HYDROXYCAMPTOTHECIN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Small Cell Lung Carcinoma
DNA topoisomerase I inhibitor
7-ETHYL-10-HYDROXYCAMPTOTHECIN
×
Maximum Phase:
2
First Approval:
None
UNII:
0H43101T0J
Molecule Type:
Small molecule
Molecular Formula:
C22H20N2O5
Molecular Weight:
392.41
AlogP:
2.35
PSA:
101.65
HBD:
2.0
HBA:
#RotB:
2.0
Source:
REFAMETINIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
REFAMETINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
JPX07AFM0N
Molecule Type:
Small molecule
Molecular Formula:
C19H20F3IN2O5S
Molecular Weight:
572.34
AlogP:
3.48
PSA:
107.89
HBD:
4.0
HBA:
#RotB:
9.0
Source:
BALAPIRAVIR
2
Small molecule
Investigational
Unknown
Unknown
Severe Dengue; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
BALAPIRAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
VOT0LP7I9K
Molecule Type:
Small molecule
Molecular Formula:
C21H30N6O8
Molecular Weight:
494.51
AlogP:
1.7
PSA:
197.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
MK-2461
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
MK-2461
×
Maximum Phase:
2
First Approval:
None
UNII:
4200RD53XF
Molecule Type:
Small molecule
Molecular Formula:
C24H25N5O5S
Molecular Weight:
495.56
AlogP:
2.15
PSA:
115.65
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PATIDEGIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Pancreatic Neoplasms; Carcinoma, Basal Cell; Chondrosarcoma; Basal Cell Nevus Syndrome
Smoothened homolog antagonist
PATIDEGIB
×
Maximum Phase:
2
First Approval:
None
UNII:
JT96FPU35X
Molecule Type:
Small molecule
Molecular Formula:
C29H48N2O3S
Molecular Weight:
504.78
AlogP:
5.03
PSA:
67.43
HBD:
2.0
HBA:
#RotB:
2.0
Source:
AFELETECAN HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Renal Cell
Unknown
AFELETECAN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
DTJ7VPW43J
Molecule Type:
Small molecule
Molecular Formula:
C45H50ClN7O11S
Molecular Weight:
932.45
AlogP:
2.95
PSA:
237.48
HBD:
6.0
HBA:
#RotB:
13.0
Source:
UK-453,061
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UK-453,061
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MITEMCINAL FUMARATE
2
Small molecule
Investigational
Unknown
Unknown
Gastroparesis
Motilin receptor agonist
MITEMCINAL FUMARATE
×
Maximum Phase:
2
First Approval:
None
UNII:
XU63LQ260J
Molecule Type:
Small molecule
Molecular Formula:
C44H73NO16
Molecular Weight:
872.06
AlogP:
4.53
PSA:
151.68
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BI-187004
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
11-beta-hydroxysteroid dehydrogenase 1 inhibitor
BI-187004
×
Maximum Phase:
2
First Approval:
None
UNII:
280XKM6Z2K
Molecule Type:
Small molecule
Molecular Formula:
C21H18N4O
Molecular Weight:
342.4
AlogP:
3.38
PSA:
72.78
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TETRACHLORODECAOXIDE
2
Small molecule
Investigational
Unknown
Unknown
Wounds and Injuries
Unknown
TETRACHLORODECAOXIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
549BT7IE1Q
Molecule Type:
Small molecule
Molecular Formula:
H2Cl4O11-4
Molecular Weight:
319.82
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MOL-4239
2
Small molecule
Investigational
Unknown
Unknown
Mycosis Fungoides; Psoriasis
Unknown
MOL-4239
×
Maximum Phase:
2
First Approval:
None
UNII:
PTN9LJL6PY
Molecule Type:
Small molecule
Molecular Formula:
C19H16BrN3O
Molecular Weight:
382.26
AlogP:
4.18
PSA:
65.78
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ABT-384
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
11-beta-hydroxysteroid dehydrogenase 1 inhibitor
ABT-384
×
Maximum Phase:
2
First Approval:
None
UNII:
R5TH77F919
Molecule Type:
Small molecule
Molecular Formula:
C25H34F3N5O2
Molecular Weight:
493.57
AlogP:
2.8
PSA:
91.56
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ARHALOFENATE
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Gout
Peroxisome proliferator-activated receptor gamma modulator
ARHALOFENATE
×
Maximum Phase:
2
First Approval:
None
UNII:
1P01UJR9X1
Molecule Type:
Small molecule
Molecular Formula:
C19H17ClF3NO4
Molecular Weight:
415.8
AlogP:
4.16
PSA:
64.63
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ELSAMITRUCIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELSAMITRUCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
ZTV0FOB6NU
Molecule Type:
Small molecule
Molecular Formula:
C33H35NO13
Molecular Weight:
653.64
AlogP:
1.73
PSA:
213.51
HBD:
5.0
HBA:
#RotB:
5.0
Source:
EMAPUNIL
2
Small molecule
Investigational
Unknown
Unknown
Anxiety
Translocator protein agonist
EMAPUNIL
×
Maximum Phase:
2
First Approval:
None
UNII:
OG837L732J
Molecule Type:
Small molecule
Molecular Formula:
C23H23N5O2
Molecular Weight:
401.47
AlogP:
2.85
PSA:
73.02
HBD:
0.0
HBA:
#RotB:
6.0
Source:
COTININE FUMARATE
2
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder
Unknown
COTININE FUMARATE
×
Maximum Phase:
2
First Approval:
None
UNII:
6ZAF060BHS
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O6
Molecular Weight:
468.51
AlogP:
1.37
PSA:
33.2
HBD:
0.0
HBA:
#RotB:
1.0
Source:
MK-6913
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Estrogen receptor agonist
MK-6913
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H27N3O2
Molecular Weight:
401.51
AlogP:
4.94
PSA:
57.01
HBD:
0.0
HBA:
#RotB:
4.0
Source:
LY545694
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies
Metabotropic glutamate receptor 5 antagonist
LY545694
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BELVARAFENIB
2
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neoplasms
RAF serine/threonine protein kinase inhibitor
BELVARAFENIB
×
Maximum Phase:
2
First Approval:
None
UNII:
31M3WLJ3KG
Molecule Type:
Small molecule
Molecular Formula:
C23H16ClFN6OS
Molecular Weight:
478.94
AlogP:
5.92
PSA:
105.82
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TRABODENOSON
2
Small molecule
Investigational
Unknown
Unknown
Glaucoma, Open-Angle; Ocular Hypertension
Adenosine A1 receptor agonist
TRABODENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
1T237110W4
Molecule Type:
Small molecule
Molecular Formula:
C15H20N6O6
Molecular Weight:
380.36
AlogP:
0.01
PSA:
157.69
HBD:
3.0
HBA:
#RotB:
6.0
Source:
1
2
…
124
125
126
127
128
129
130
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA